Maravai Lifesciences Inc (NASDAQ: MRVI) — Perfil da empresa, notícias e dados financeiros
Maravai Lifesciences provides reagents for drug and vaccine development, focusing on biotechnology advancements.
Maravai Lifesciences Inc
Maravai Lifesciences (NASDAQ:MRVI) focuses on providing reagents and products for researchers and companies developing therapeutic drugs, vaccines, and diagnostics. They specialize in nucleic acid synthesis, mRNA production for vaccine and therapeutic development, and antibody discovery. Their operations span across critical areas of life sciences and biotechnology, with an emphasis on supporting advancements in public health and innovation in the medical field. Maravai's objectives revolve around leveraging their expertise to accelerate scientific discoveries and improve patient care through the provision of high-quality, essential research materials and services.
Resumo
Operações
Produtos e/ou serviços de Maravai Lifesciences Inc
- CleanCap Reagent for mRNA capping, enhancing the stability and efficiency of mRNA vaccines and therapeutics.
- TriLink Biotechnologies offers custom oligonucleotide synthesis for diagnostics and therapeutics.
- GMP Nucleotides for molecular diagnostics and RNA-based therapeutics, ensuring high-quality production standards.
- Glen Research provides reagents for DNA and RNA synthesizing professionals, focusing on oligonucleotide modifications.
- Cygnus Technologies offers analytical tools for process impurity testing, crucial for biopharmaceutical manufacturing.
- VectorBuilder platform designs and manufactures custom vectors for gene delivery, aiding gene therapy research.
equipe executiva do Maravai Lifesciences Inc
- Robert Andrew EckertChairman of the Board
- Bernd BrustCEO & Director
- Rajesh J. AsorpotaEVP & Chief Financial Officer
- Kurt A. OreshackExecutive VP, General Counsel & Secretary
- Christine DolanExecutive VP & GM of Cygnus Technologies
- Chanfeng ZhaoSenior VP & Chief Scientific Officer
- Debra HartSenior Director of Investor Relations
- Judith A. SoleckiSenior VP & Chief Human Resources Officer
- Kate E. BroderickExecutive Vice President
- Christopher C. BenoitExecutive VP & Advisor
Principais indicadores financeiros
Resultados divulgados pela Maravai Lifesciences Inc, em USD.
- Cap. de mercado
- 3,1 bi
- Receita (TTM)
- 208,8 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.5
- Dividend yield
- —
- Margem de lucro
- -37.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 185,7 mi | -6,7 mi | -130,8 mi | |
| 259,2 mi | -235,6 mi | -144,8 mi | |
| 288,9 mi | -31,6 mi | -119 mi | |
| 883 mi | 574,2 mi | 220,2 mi |